CATX

#2551
Perspective Therapeutics, Inc. Common Stock
3.9 4 USD
-1.99%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
3.90
3.97
Year Range
1.96
6.16
Daily Change
-1.99%
Monthly Change
-0.25%
6 month change
+66.95%
Year Change
+42.24%
Previous Close
4.0 2
Open
3.9 7
Low
3.9 0
High
3.9 7
Volume
529
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 449.34 M
  • Employee 166
  • Founded 2004
  • CEO N/A
  • Website www.perspectivetherapeutics.com
  • Headquarter Delaware, United States
  • FIGI BBG000BG5HT7
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.96
Price to sales ratio
229.62

Perspective Therapeutics, Inc. Common Stock

Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu. The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354.

News